Dr. Reddy's Laboratories (RDY: Quote) announced it has launched Zenatane in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane, in the US market on March 28, 2013 following the approval by the FDA of ANDA for Zenatane 10 mg, 20 mg and 40 mg.
The company noted that total market had U.S. sales of approximately $309 million for the most recent twelve months ending January 2013 according to IMS Health.
Click here to receive FREE breaking news email alerts for Dr Reddy Laboratories Ltd and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org